8158 — China Regenerative Medicine International Cashflow Statement
0.000.00%
Last trade - 00:00- HK$85.19m
- HK$132.05m
- HK$69.49m
Annual cashflow statement for China Regenerative Medicine International, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -457 | -142 | 64.3 | 8.27 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 265 | -137 | -41.2 | 8.06 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 117 | -122 | -26.2 | -34.1 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -23.3 | -399 | -3.02 | -17.7 | — |
| Capital Expenditures | -5.74 | 0 | -0.809 | -2.59 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 413 | 327 | 10.1 | 0.001 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 407 | 327 | 9.27 | -2.59 | — |
| Financing Cash Flow Items | -3.69 | 29.7 | -0.174 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -394 | 67.4 | -1.39 | 7.32 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.8 | -4.52 | 5.16 | -8.08 | — |